Studies on the bioequivalence of different strengths of tablets containing clarithromycin

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 9 A, 2004, Pages 588-593

  Koytchev, Rossen ^a,e   Ozalp, Yildiz ^b   Erenmemisoglu, Aydin ^c   Van Der Meer, Mike John ^d   Alpan, Recep Serdar ^b  

^a Coop Clin Drug R and D ^*  (Germany)

^b EIS Eczacibasi Ilac Sanayi ve T   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

^d Trident Bioanalytics Ltd   (Ireland)

^e Coop Clin Drug R and D AG ^*  (Germany)

Author keywords

CAS 81103 11 9; Clarithromycin, bioequivalence, clinical pharmacokinetics; Klaromin

Indexed keywords

14 HYDROXYCLARITHROMYCIN; CLARITHROMYCIN; DRUG METABOLITE; KLAROMIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG TOLERANCE; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NAUSEA; NORMAL HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; SYNCOPE; TABLET FORMULATION;

EID: 4644351052     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297054     Document Type: Article

References (10)

1. Langtry, H. D., Brogden, R. N., Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Drugs 53, 973 (1997)
2. Rodvold, K. A., Clinical pharmacokinetics of clarithromycin. Clin. Pharmacokinet. 37, 385 (1999)
3. Ferrero, J. L., Bopp, B. A., Marsh, K. C. et al., Metabolism and disposition of clarithromycin in man. Drug. Metab. Dispos. 18, 441 (1990)
4. Fraschini, F., Scaglione, F., Demartini, G., Clarithromycin clinical pharmacokinetics. Clin. Pharmacokinet. 25, 189 (1993)
5. Davey, P. G., The pharmacokinetics of clarithromycin and its 14-metabolite. J. Hosp. Infect. 19 (Suppl. A), 29 (1991)
6. Peters, D. H., Clissold, S. P., Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs 44, 117 (1992)
7. Hauschke, D., Steinijans, V., Diletti, E., A distribution free procedure for the statistical analysis of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 28, 72 (1990)
8. Chu, S. Y., Sennello, L. T., Bunnell, S. T. et al., Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. Antimicrob. Agents Chemother. 36, 2447 (1992)
9. CPMP Note for Guidance: Investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98 (1998)
10. Chu, S. Y., Deaton, R., Cavanaugh J. et al., Absolute bioavailability of clarithromycin after oral administration in humans. Antimicrob. Agents Chemother. 36, 1147 (1992)